Share
𝕏 Facebook LinkedIn

Preliminary study of pulsed-electromagnetic fields effects on endothelial (HUVEC) cell secretions--modulation of the thrombo-hemorrhagic balance.

PAPER pubmed Electromagnetic biology and medicine 2008 In vitro study Effect: mixed Evidence: Very low

Abstract

We investigated the role of low-amplitude magnetic pulse with low repetition frequency superimposed on the environmental electromagnetic field (EMF) on the secretion of anti-aggregant (Prostacyclin or PGI(2)) and pro-aggregant (Thromboxane A(2)) agents in endothelial cells of the human umbilical cord vein (HUVEC). We established that magnetic pulse exposure modulates both PGI(2) and TXA(2). These modulations depend on the frequency, width of the pulse, and intensity of the magnetic field. Moreover, we corroborated previous results obtained with an endothelial cell line (EaHy-926), concerning the increased thrombo-embolic risk for the 1 Hz frequency.

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
mixed
Population
Human umbilical cord vein endothelial cells (HUVEC)
Sample size
—
Exposure
pulsed magnetic field superimposed on environmental EMF
Evidence strength
Very low
Confidence: 74% · Peer-reviewed: yes

Main findings

Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.

Outcomes measured

  • Secretion/modulation of prostacyclin (PGI2)
  • Secretion/modulation of thromboxane A2 (TXA2)
  • Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)

Limitations

  • In vitro cell model; findings may not translate to humans
  • Exposure parameters not fully specified in abstract (e.g., exact field strengths, pulse widths, exposure duration)
  • Sample size and statistical details not reported in abstract

Suggested hubs

  • elf-emf (0.6)
    Low repetition frequency (e.g., 1 Hz) pulsed magnetic field exposure.
  • mechanisms-in-vitro (0.85)
    In vitro endothelial cell secretion changes (PGI2/TXA2) under pulsed magnetic field exposure.
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": null,
        "source": "pulsed magnetic field superimposed on environmental EMF",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": null
    },
    "population": "Human umbilical cord vein endothelial cells (HUVEC)",
    "sample_size": null,
    "outcomes": [
        "Secretion/modulation of prostacyclin (PGI2)",
        "Secretion/modulation of thromboxane A2 (TXA2)",
        "Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)"
    ],
    "main_findings": "Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.",
    "effect_direction": "mixed",
    "limitations": [
        "In vitro cell model; findings may not translate to humans",
        "Exposure parameters not fully specified in abstract (e.g., exact field strengths, pulse widths, exposure duration)",
        "Sample size and statistical details not reported in abstract"
    ],
    "evidence_strength": "very_low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "pulsed electromagnetic fields",
        "magnetic pulse",
        "environmental EMF",
        "HUVEC",
        "endothelial cells",
        "prostacyclin",
        "PGI2",
        "thromboxane A2",
        "TXA2",
        "platelet aggregation",
        "thrombo-hemorrhagic balance",
        "thrombo-embolic risk",
        "1 Hz"
    ],
    "suggested_hubs": [
        {
            "slug": "elf-emf",
            "weight": 0.59999999999999997779553950749686919152736663818359375,
            "reason": "Low repetition frequency (e.g., 1 Hz) pulsed magnetic field exposure."
        },
        {
            "slug": "mechanisms-in-vitro",
            "weight": 0.84999999999999997779553950749686919152736663818359375,
            "reason": "In vitro endothelial cell secretion changes (PGI2/TXA2) under pulsed magnetic field exposure."
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.